Emergent BioSolutions EBS
NYSE EBS
$6.10 +0.00 (+0.00%)
As of: Nov 10, 2026 · 1:23 PM EST

Emergent BioSolutions (EBS) Revenue (2011 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Revenue (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.40 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 17.40 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 15.38 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 16.58 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn 110.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 110.00 Mn
Jun 30, 2026 234.30 Mn
Mar 31, 2026 156.10 Mn
Dec 31, 2025 148.70 Mn
Sep 30, 2025 231.10 Mn
Jun 30, 2025 140.90 Mn
Mar 31, 2025 222.20 Mn
Dec 31, 2024 194.70 Mn
Sep 30, 2024 293.80 Mn
Jun 30, 2024 254.70 Mn
Mar 31, 2024 300.40 Mn
Dec 31, 2023 276.60 Mn
Sep 30, 2023 270.50 Mn
Jun 30, 2023 337.90 Mn
Mar 31, 2023 164.30 Mn
Dec 31, 2022 330.20 Mn
Sep 30, 2022 239.90 Mn
Jun 30, 2022 242.60 Mn
Mar 31, 2022 304.80 Mn
Dec 31, 2021 732.90 Mn
API Access

Emergent BioSolutions Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=EBS&period=max&api_key=YOUR_API_KEY